Jia-Qi Xu

Jia-Qi Xu

Auto-generated profile, based on publicly available information

Jia-Qi Xu

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JXJia-Qi Xu
Jia-Qi Xu
SSShi-Bing Su
Shi-Bing Su
CCC. Y. Chen
C. Y. Chen
JGJ. Gao
J. Gao
ZCZ. M. Cao
Z. M. Cao
YHYuanjia Hu
Yuanjia Hu
The hepatitis B virus (HBV) is one of the major viral infection problems worldwide in public health. The exclusive proprietary Chinese medicine Ganweikang (GWK) tablet has been marketed for years in the treatment of chronic hepatitis B (CHB). However, the pharmacodynamic material basis and underlying mechanism of GWK are not completely clear. This study is aimed at investigating the pharmacological mechanism of the GWK tablet in the treatment of CHB. The chemical ingredient information was obtained from the Traditional Chinese Medicine Database and Analysis Platform (TCMSP), Traditional Chinese Medicines Integrated Database (TCMID), and Shanghai Institute of Organic Chemistry of CAS. Ingredients and disease‐related targets were defined by a combination of differentially expressed genes from CHB transcriptome data and open‐source databases. Target‐pathway‐target (TPT) network analysis, molecular docking, and chemical composition analysis were adopted to further verify the key targets and corresponding active ingredients of GWK. Eight herbs of GWK were correlated to 330 compounds with positive oral bioavailability, and 199 correlated targets were identified. The TPT network was constructed based on the 146 enriched targets by KEGG pathway analysis, significantly associated with 95 pathways. Twenty‐five nonvolatile components and 25 volatile components in GWK were identified in UPLC‐QTOF/MS and GC‐MS chromatograms. The key active ingredients of GWK include ferulic acid, oleanolic acid, ursolic acid, tormentic acid, 11‐deoxyglycyrrhetic acid, dibenzoyl methane, anisaldehyde, wogonin, protocatechuic acid, psoralen, caffeate, dimethylcaffeic acid, vanillin, β‐amyrenyl acetate, formonentin, aristololactam IIIa, and 7‐methoxy‐2‐methyl isoflavone, associated with targets CA2, NFKB1, RELA, AKT1, JUN, CA1, CA6, IKBKG, FOS, EP300, CREB1, STAT1, MMP9, CDK2, ABCB1, and ABCG2.